# OXACILLIN SODIUM
> **ANDA206681** · Abbreviated New Drug Application (Generic) · Sponsor: PIRAMAL CRITICAL · Approved 2017-09-11
## Drug
- **FDA Application Number:** ANDA206681
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXACILLIN SODIUM
- **Generic name:** Oxacillin Sodium
- **Active ingredients:** OXACILLIN SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** PIRAMAL CRITICAL
- **First approval:** 2017-09-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206681)
---
*AI Analytics · CC0 1.0*